PMC:7172841 / 1392-1678 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T15","span":{"begin":80,"end":83},"obj":"Body_part"},{"id":"T16","span":{"begin":95,"end":104},"obj":"Body_part"},{"id":"T17","span":{"begin":112,"end":116},"obj":"Body_part"},{"id":"T18","span":{"begin":121,"end":128},"obj":"Body_part"},{"id":"T19","span":{"begin":124,"end":128},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma62864"},{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A18","pred":"fma_id","subj":"T18","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"n syndrome\n• Severe respiratory failure is associated with a major decrease of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation\n\nProper management"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T20","span":{"begin":21,"end":40},"obj":"Disease"},{"id":"T21","span":{"begin":170,"end":178},"obj":"Disease"},{"id":"T22","span":{"begin":225,"end":233},"obj":"Disease"},{"id":"T23","span":{"begin":225,"end":229},"obj":"Disease"}],"attributes":[{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0021113"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"n syndrome\n• Severe respiratory failure is associated with a major decrease of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation\n\nProper management"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T13","span":{"begin":60,"end":61},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T14","span":{"begin":95,"end":104},"obj":"http://purl.obolibrary.org/obo/CL_0000576"},{"id":"T15","span":{"begin":108,"end":111},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T16","span":{"begin":112,"end":116},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T17","span":{"begin":121,"end":128},"obj":"http://purl.obolibrary.org/obo/CL_0000623"}],"text":"n syndrome\n• Severe respiratory failure is associated with a major decrease of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation\n\nProper management"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T12","span":{"begin":84,"end":86},"obj":"Chemical"},{"id":"T13","span":{"begin":182,"end":184},"obj":"Chemical"}],"attributes":[{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A14","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"n syndrome\n• Severe respiratory failure is associated with a major decrease of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation\n\nProper management"}

{"project":"LitCovid-sentences","denotations":[{"id":"T14","span":{"begin":11,"end":104},"obj":"Sentence"},{"id":"T15","span":{"begin":105,"end":178},"obj":"Sentence"},{"id":"T16","span":{"begin":179,"end":267},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"n syndrome\n• Severe respiratory failure is associated with a major decrease of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation\n\nProper management"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":21,"end":40},"obj":"Phenotype"},{"id":"T10","span":{"begin":247,"end":267},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002878"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002958"}],"text":"n syndrome\n• Severe respiratory failure is associated with a major decrease of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation\n\nProper management"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T49","span":{"begin":21,"end":32},"obj":"UBERON:0001004"},{"id":"T50","span":{"begin":80,"end":83},"obj":"PR:000029150"},{"id":"T51","span":{"begin":90,"end":94},"obj":"PR:000001889"},{"id":"T52","span":{"begin":95,"end":104},"obj":"CL:0000576"},{"id":"T53","span":{"begin":170,"end":178},"obj":"SP_7"},{"id":"T54","span":{"begin":182,"end":186},"obj":"PR:000001393"},{"id":"T55","span":{"begin":195,"end":206},"obj":"DG_35"},{"id":"T56","span":{"begin":225,"end":235},"obj":"SP_7"},{"id":"T57","span":{"begin":254,"end":267},"obj":"GO:0065007"},{"id":"T35889","span":{"begin":21,"end":32},"obj":"UBERON:0001004"},{"id":"T52417","span":{"begin":80,"end":83},"obj":"PR:000029150"},{"id":"T73916","span":{"begin":90,"end":94},"obj":"PR:000001889"},{"id":"T86003","span":{"begin":95,"end":104},"obj":"CL:0000576"},{"id":"T91561","span":{"begin":170,"end":178},"obj":"SP_7"},{"id":"T288","span":{"begin":182,"end":186},"obj":"PR:000001393"},{"id":"T45776","span":{"begin":195,"end":206},"obj":"DG_35"},{"id":"T71931","span":{"begin":225,"end":235},"obj":"SP_7"},{"id":"T97850","span":{"begin":254,"end":267},"obj":"GO:0065007"}],"text":"n syndrome\n• Severe respiratory failure is associated with a major decrease of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation\n\nProper management"}

{"project":"LitCovid-PubTator","denotations":[{"id":"74","span":{"begin":90,"end":94},"obj":"Gene"},{"id":"75","span":{"begin":21,"end":40},"obj":"Disease"},{"id":"79","span":{"begin":108,"end":111},"obj":"Gene"},{"id":"80","span":{"begin":121,"end":139},"obj":"Disease"},{"id":"81","span":{"begin":170,"end":178},"obj":"Disease"},{"id":"85","span":{"begin":182,"end":186},"obj":"Gene"},{"id":"86","span":{"begin":225,"end":235},"obj":"Species"},{"id":"87","span":{"begin":195,"end":206},"obj":"Chemical"}],"attributes":[{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"Gene:929"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"MESH:D012131"},{"id":"A79","pred":"tao:has_database_id","subj":"79","obj":"Gene:920"},{"id":"A80","pred":"tao:has_database_id","subj":"80","obj":"MESH:D054066"},{"id":"A81","pred":"tao:has_database_id","subj":"81","obj":"MESH:C000657245"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"Gene:3569"},{"id":"A86","pred":"tao:has_database_id","subj":"86","obj":"Tax:2697049"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"n syndrome\n• Severe respiratory failure is associated with a major decrease of HLA-DR on CD14 monocytes\n• CD4 cell and NK cell cytopenias are characteristics of severe COVID-19\n• IL-6 blocker Tocilizumab partially rescues SARS-CoV-2-associated immune dysregulation\n\nProper management"}